PL1-OX40 + anti-OX40 Ab treatment (i.t.)significantly decreased the tumor growth and prolonged survival in comparison to treatment with PBS and PL1-OX40 + anti-OX40 Ab in both tumor models (Supplementary Fig. 9a–f). The gene discussed is TNFRSF4; the disease is neoplasm.